AXA Mansard Launches iMED International Health Plan

In Short

• AXA Mansard Health has launched iMED, an international healthcare plan for Nigerians.
• The plan includes cover for cancer, chronic and complex conditions, critical procedures, and emergency medical assistance.
• Members can access accredited providers in Nigeria, the United States, the United Kingdom, and Dubai.

What Happened

AXA Mansard Health, part of AXA Mansard, says its iMED international healthcare plan is now available to Nigerians who want medical cover beyond local hospital networks.

According to the company, iMED covers cancer treatment, chronic and complex conditions, and critical procedures. It also includes international emergency medical assistance, which typically means support during medical emergencies while traveling, plus coordination of care and evacuation when needed.

The plan is positioned around access to “accredited healthcare providers” across multiple markets, including Nigeria, the US, the UK, and Dubai. In practical terms, this is about giving members a wider network of hospitals and specialists, and reducing the need to pay out of pocket when seeking care abroad.

While the company did not publish pricing details in the announcement shared on August 20, 2026, the product fits a common demand pattern in Nigeria. Many families and employers look for international health insurance when they expect cross-border care, especially for complex treatment pathways like oncology.

Why It Matters

For Nigerian consumers, health insurance often breaks down at the point where care gets expensive, long-term, or specialist-led. Cancer care and chronic conditions can require repeated tests, specialist consultations, and extended treatment cycles, and costs can rise quickly.

For businesses, international plans can be an employee benefit for executives and globally mobile teams. It can also be a risk management tool, especially when local capacity for certain procedures is limited or waiting times are long.

For the wider health insurance market, iMED adds pressure on local insurers and HMOs to improve provider quality, claims processing, and cross-border partnerships. The key question will be how seamless the care experience is across countries, including approvals and claims, not just the promise of access.